TCM Biotech International Corp. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 273.517 million compared to TWD 253.552 million a year ago. Operating income was TWD 3.523 million compared to TWD 15.221 million a year ago. Net income was TWD 2.606 million compared to TWD 14.207 million a year ago. Basic earnings per share was TWD 0.06 compared to TWD 0.3 a year ago.